Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
6 plans require enrollment prior to initiating the drug, while one plan required enrollment as an adjunct to therapy
Why the Liver Matters for Copper Peptide Therapy The liver is the central regulator of copper homeostasis
Your options are: (1) enrolling in a Phase 3 clinical trial (free, pharmaceutical-grade, medically supervised), (2) compounded retatrutide from telehealth platforms ($200$500/month with prescription), or (3) research peptides from grey-market vendors ($150$500/month, no prescription, quality varies)
Usage & Storage Description Retatrutide is a novel triple receptor agonist targeting GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors simultaneously
Planning for long-term medication use or developing robust lifestyle habits during initial treatment helps manage this reality
US$ 24.14
US$ 20.55
US$ 26.49
US$ 26.32
US$ 23.38
